HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Johannes Attems Selected Research

Epitopes

1/2020Investigating the presence of doubly phosphorylated α-synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Johannes Attems Research Topics

Disease

45Alzheimer Disease (Alzheimer's Disease)
12/2023 - 04/2004
34Dementia (Dementias)
02/2024 - 06/2007
21Parkinson Disease (Parkinson's Disease)
02/2024 - 04/2012
14Cognitive Dysfunction
12/2023 - 06/2007
12Neurodegenerative Diseases (Neurodegenerative Disease)
10/2022 - 05/2011
10Lewy Body Disease (Lewy Body Dementia)
06/2023 - 05/2015
9Tauopathies
04/2023 - 04/2010
8Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2021 - 04/2004
7Neoplasms (Cancer)
01/2017 - 06/2005
6Amyloid Plaque
01/2021 - 11/2013
4Breast Neoplasms (Breast Cancer)
01/2017 - 07/2005
3Atrophy
10/2022 - 07/2013
3Disease Progression
01/2019 - 04/2014
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2010 - 06/2005
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
11/2023 - 01/2022
2Hypertension (High Blood Pressure)
12/2021 - 02/2014
2Wallerian Degeneration
12/2021 - 09/2017
2Demyelinating Diseases (Demyelinating Disease)
12/2021 - 01/2019
2Synucleinopathies
01/2020 - 01/2019
2Neuroinflammatory Diseases
01/2018 - 04/2014
2Hallucinations (Hallucination)
06/2017 - 01/2016
2Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2017 - 08/2014
2Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
01/2017 - 07/2013
2Gliosis
02/2016 - 01/2016
2Insulinoma
01/2016 - 04/2010
2Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
11/2014 - 04/2012
2Neoplasm Metastasis (Metastasis)
07/2014 - 07/2010
1Brain Diseases (Brain Disorder)
12/2023
1Cardiovascular Diseases (Cardiovascular Disease)
12/2023
1Hearing Loss (Hearing Impairment)
11/2023
1Multiple System Atrophy
10/2022
1Autonomic Nervous System Diseases (Dysautonomia)
10/2022
1Cerebellar Ataxia (Dysmetria)
10/2022
1Cerebellar Diseases (Cerebellar Syndrome)
10/2022
1Parkinsonian Disorders (Parkinsonism)
10/2022
1Striatonigral Degeneration
10/2022
1Mitochondrial Diseases (Mitochondrial Disease)
01/2022
1Globoid Cell Leukodystrophy (Krabbe Disease)
01/2022
1Arteriolosclerosis
12/2021
1Rare Diseases (Rare Disease)
10/2021
1Autistic Disorder (Autism)
01/2021
1Intellectual Disability (Idiocy)
01/2021
1Amyloidosis
01/2020
1Genetic Risk Score
01/2020
1Proteostasis Deficiencies
01/2020
1Kuru
03/2019
1Movement Disorders (Movement Disorder)
01/2019
1limbic-predominant age-related TDP-43 encephalopathy
01/2019
1REM Sleep Behavior Disorder
07/2017

Drug/Important Bio-Agent (IBA)

27Proteins (Proteins, Gene)FDA Link
01/2022 - 05/2007
26Amyloid (Amyloid Fibrils)IBA
12/2023 - 09/2012
17SynucleinsIBA
02/2024 - 09/2012
15Biomarkers (Surrogate Marker)IBA
08/2019 - 08/2008
10Amyloid beta-PeptidesIBA
01/2022 - 04/2004
9alpha-SynucleinIBA
10/2022 - 01/2007
5Apolipoproteins E (ApoE)IBA
12/2021 - 08/2010
5Peptides (Polypeptides)IBA
01/2021 - 09/2005
4Protein Isoforms (Isoforms)IBA
04/2023 - 01/2016
4Protein AggregatesIBA
01/2019 - 08/2014
4Trastuzumab (Herceptin)FDA Link
01/2017 - 07/2005
3Dopamine (Intropin)FDA LinkGeneric
06/2023 - 04/2012
3Peptide Hydrolases (Proteases)FDA Link
12/2021 - 08/2014
3SecretagoginsIBA
04/2012 - 04/2010
2ProteomeIBA
01/2022 - 04/2012
2Myelin-Associated GlycoproteinIBA
12/2021 - 09/2017
2CalpainIBA
12/2021 - 09/2017
22- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA
02/2021 - 01/2017
2AntibodiesIBA
01/2020 - 05/2013
2Mitochondrial DNA (mtDNA)IBA
02/2017 - 03/2016
2UbiquitinIBA
01/2017 - 07/2013
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
02/2016 - 03/2006
2tau Proteins (tau Protein)IBA
04/2014 - 05/2011
2Cholinergic Agents (Cholinergics)IBA
04/2014 - 08/2012
2Calcium-Binding ProteinsIBA
05/2011 - 04/2010
1Serine (L-Serine)FDA Link
12/2022
1AutoantibodiesIBA
10/2022
1Fatty Acids (Saturated Fatty Acids)IBA
01/2022
1PrionsIBA
01/2022
1SphingolipidsIBA
01/2022
1Psychosine (Galactosylsphingosine)IBA
01/2022
1LigandsIBA
01/2021
1ras ProteinsIBA
01/2021
1Adrenergic Receptors (Adrenergic Receptor)IBA
09/2020
1montelukast (Singulair)FDA Link
01/2020
1EpitopesIBA
01/2020
1DNA-Binding Proteins (DNA Binding Protein)IBA
01/2020
1Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA
01/2020
1Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
01/2020
1Prion ProteinsIBA
03/2019
1Blood Proteins (Serum Proteins)IBA
01/2019
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2019
1Fibrinogen (Factor I)FDA Link
01/2019
1Poly TIBA
01/2019
1Cathepsin DIBA
01/2019
1ioflupaneIBA
01/2018
1Presenilin-1IBA
01/2018
13-Iodobenzylguanidine (Iobenguane)IBA
07/2017
1NucleotidesIBA
02/2017
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2017

Therapy/Procedure

6Therapeutics
04/2023 - 03/2006